AIMS/HYPOTHESIS: Diabetic nephropathy is a major diabetic complication, and diabetes is the leading cause of end-stage renal disease (ESRD). Family studies suggest a hereditary component for diabetic nephropathy. However, only a few genes have been associated with diabetic nephropathy or ESRD in diabetic patients. Our aim was to detect novel genetic variants associated with diabetic nephropathy and ESRD. METHODS: We exploited a novel algorithm, 'Bag of Naive Bayes', whose marker selection strategy is complementary to that of conventional genome-wide association models based on univariate association tests. The analysis was performed on a genome-wide association study of 3,464 patients with type 1 diabetes from the Finnish Diabetic Nephropathy (FinnDiane) Study and subsequently replicated with 4,263 type 1 diabetes patients from the Steno Diabetes Centre, the All Ireland-Warren 3-Genetics of Kidneys in Diabetes UK collection (UK-Republic of Ireland) and the Genetics of Kidneys in Diabetes US Study (GoKinD US). RESULTS: Five genetic loci (WNT4/ZBTB40-rs12137135, RGMA/MCTP2-rs17709344, MAPRE1P2-rs1670754, SEMA6D/SLC24A5-rs12917114 and SIK1-rs2838302) were associated with ESRD in the FinnDiane study. An association between ESRD and rs17709344, tagging the previously identified rs12437854 and located between the RGMA and MCTP2 genes, was replicated in independent case-control cohorts. rs12917114 near SEMA6D was associated with ESRD in the replication cohorts under the genotypic model (p < 0.05), and rs12137135 upstream of WNT4 was associated with ESRD in Steno. CONCLUSIONS/ INTERPRETATION: This study supports the previously identified findings on the RGMA/MCTP2 region and suggests novel susceptibility loci for ESRD. This highlights the importance of applying complementary statistical methods to detect novel genetic variants in diabetic nephropathy and, in general, in complex diseases.
AIMS/HYPOTHESIS: Diabetic nephropathy is a major diabetic complication, and diabetes is the leading cause of end-stage renal disease (ESRD). Family studies suggest a hereditary component for diabetic nephropathy. However, only a few genes have been associated with diabetic nephropathy or ESRD in diabeticpatients. Our aim was to detect novel genetic variants associated with diabetic nephropathy and ESRD. METHODS: We exploited a novel algorithm, 'Bag of Naive Bayes', whose marker selection strategy is complementary to that of conventional genome-wide association models based on univariate association tests. The analysis was performed on a genome-wide association study of 3,464 patients with type 1 diabetes from the Finnish Diabetic Nephropathy (FinnDiane) Study and subsequently replicated with 4,263 type 1 diabetespatients from the Steno Diabetes Centre, the All Ireland-Warren 3-Genetics of Kidneys in Diabetes UK collection (UK-Republic of Ireland) and the Genetics of Kidneys in Diabetes US Study (GoKinD US). RESULTS: Five genetic loci (WNT4/ZBTB40-rs12137135, RGMA/MCTP2-rs17709344, MAPRE1P2-rs1670754, SEMA6D/SLC24A5-rs12917114 and SIK1-rs2838302) were associated with ESRD in the FinnDiane study. An association between ESRD and rs17709344, tagging the previously identified rs12437854 and located between the RGMA and MCTP2 genes, was replicated in independent case-control cohorts. rs12917114 near SEMA6D was associated with ESRD in the replication cohorts under the genotypic model (p < 0.05), and rs12137135 upstream of WNT4 was associated with ESRD in Steno. CONCLUSIONS/ INTERPRETATION: This study supports the previously identified findings on the RGMA/MCTP2 region and suggests novel susceptibility loci for ESRD. This highlights the importance of applying complementary statistical methods to detect novel genetic variants in diabetic nephropathy and, in general, in complex diseases.
Authors: Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich Journal: Nat Genet Date: 2006-07-23 Impact factor: 38.330
Authors: T Zhou; X He; R Cheng; B Zhang; R R Zhang; Y Chen; Y Takahashi; A R Murray; K Lee; G Gao; J-X Ma Journal: Diabetologia Date: 2011-10-21 Impact factor: 10.122
Authors: Richard N Bergman; Darko Stefanovski; Thomas A Buchanan; Anne E Sumner; James C Reynolds; Nancy G Sebring; Anny H Xiang; Richard M Watanabe Journal: Obesity (Silver Spring) Date: 2011-03-03 Impact factor: 5.002
Authors: Carol Forsblom; Valma Harjutsalo; Lena M Thorn; Johan Wadén; Nina Tolonen; Markku Saraheimo; Daniel Gordin; John L Moran; Merlin C Thomas; Per-Henrik Groop Journal: J Am Soc Nephrol Date: 2011-02-18 Impact factor: 10.121
Authors: Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean Journal: Nature Date: 2012-11-01 Impact factor: 49.962
Authors: Niina Sandholm; Natalie Van Zuydam; Emma Ahlqvist; Thorhildur Juliusdottir; Harshal A Deshmukh; N William Rayner; Barbara Di Camillo; Carol Forsblom; Joao Fadista; Daniel Ziemek; Rany M Salem; Linda T Hiraki; Marcus Pezzolesi; David Trégouët; Emma Dahlström; Erkka Valo; Nikolay Oskolkov; Claes Ladenvall; M Loredana Marcovecchio; Jason Cooper; Francesco Sambo; Alberto Malovini; Marco Manfrini; Amy Jayne McKnight; Maria Lajer; Valma Harjutsalo; Daniel Gordin; Maija Parkkonen; Jaakko Tuomilehto; Valeriya Lyssenko; Paul M McKeigue; Stephen S Rich; Mary Julia Brosnan; Eric Fauman; Riccardo Bellazzi; Peter Rossing; Samy Hadjadj; Andrzej Krolewski; Andrew D Paterson; Jose C Florez; Joel N Hirschhorn; Alexander P Maxwell; David Dunger; Claudio Cobelli; Helen M Colhoun; Leif Groop; Mark I McCarthy; Per-Henrik Groop Journal: J Am Soc Nephrol Date: 2016-09-19 Impact factor: 10.121
Authors: Mathias Gorski; Bettina Jung; Yong Li; Pamela R Matias-Garcia; Matthias Wuttke; Stefan Coassin; Chris H L Thio; Marcus E Kleber; Thomas W Winkler; Veronika Wanner; Jin-Fang Chai; Audrey Y Chu; Massimiliano Cocca; Mary F Feitosa; Sahar Ghasemi; Anselm Hoppmann; Katrin Horn; Man Li; Teresa Nutile; Markus Scholz; Karsten B Sieber; Alexander Teumer; Adrienne Tin; Judy Wang; Bamidele O Tayo; Tarunveer S Ahluwalia; Peter Almgren; Stephan J L Bakker; Bernhard Banas; Nisha Bansal; Mary L Biggs; Eric Boerwinkle; Erwin P Bottinger; Hermann Brenner; Robert J Carroll; John Chalmers; Miao-Li Chee; Miao-Ling Chee; Ching-Yu Cheng; Josef Coresh; Martin H de Borst; Frauke Degenhardt; Kai-Uwe Eckardt; Karlhans Endlich; Andre Franke; Sandra Freitag-Wolf; Piyush Gampawar; Ron T Gansevoort; Mohsen Ghanbari; Christian Gieger; Pavel Hamet; Kevin Ho; Edith Hofer; Bernd Holleczek; Valencia Hui Xian Foo; Nina Hutri-Kähönen; Shih-Jen Hwang; M Arfan Ikram; Navya Shilpa Josyula; Mika Kähönen; Chiea-Chuen Khor; Wolfgang Koenig; Holly Kramer; Bernhard K Krämer; Brigitte Kühnel; Leslie A Lange; Terho Lehtimäki; Wolfgang Lieb; Ruth J F Loos; Mary Ann Lukas; Leo-Pekka Lyytikäinen; Christa Meisinger; Thomas Meitinger; Olle Melander; Yuri Milaneschi; Pashupati P Mishra; Nina Mononen; Josyf C Mychaleckyj; Girish N Nadkarni; Matthias Nauck; Kjell Nikus; Boting Ning; Ilja M Nolte; Michelle L O'Donoghue; Marju Orho-Melander; Sarah A Pendergrass; Brenda W J H Penninx; Michael H Preuss; Bruce M Psaty; Laura M Raffield; Olli T Raitakari; Rainer Rettig; Myriam Rheinberger; Kenneth M Rice; Alexander R Rosenkranz; Peter Rossing; Jerome I Rotter; Charumathi Sabanayagam; Helena Schmidt; Reinhold Schmidt; Ben Schöttker; Christina-Alexandra Schulz; Sanaz Sedaghat; Christian M Shaffer; Konstantin Strauch; Silke Szymczak; Kent D Taylor; Johanne Tremblay; Layal Chaker; Pim van der Harst; Peter J van der Most; Niek Verweij; Uwe Völker; Melanie Waldenberger; Lars Wallentin; Dawn M Waterworth; Harvey D White; James G Wilson; Tien-Yin Wong; Mark Woodward; Qiong Yang; Masayuki Yasuda; Laura M Yerges-Armstrong; Yan Zhang; Harold Snieder; Christoph Wanner; Carsten A Böger; Anna Köttgen; Florian Kronenberg; Cristian Pattaro; Iris M Heid Journal: Kidney Int Date: 2020-10-31 Impact factor: 18.998